Concepedia

H. O. OK

HO

Statistics

Publications

4

Citations

177

H-Index

4

Active since

1989

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

H. O. OK is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, health sciences, and molecular pharmacology.

Top concepts

MedicineHealthPharmacologyMolecular PharmacologyObesityBiophysicsImmunologyMetabolismPhysiologyAutoimmunity

Publications per year

1989–2000

4

Publications

4

A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys.

M. H. FISHER, A Amend, Tom Bach et al. · Journal of Clinical Investigation · 1998 · 115 citations · Full text

Metabolic Rate, Obesity, Molecular Pharmacology +17

Wavelength regulation in iodopsin, a cone pigment

J.G. Chen, Tadashi Nakamura, Thomas G. Ebrey et al. · Biophysical Journal · 1989 · 27 citations · Full text

Wavelength Regulation, Photoreceptor Cell, Photochemistry +6

Substituted oxazole benzenesulfonamides as potent human β3 adrenergic receptor agonists

H. O. OK, Leah Reigle, Mari R. Candelore et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 21 citations · Full text

Molecular Pharmacology, Oxazole Benzenesulfonamides, Pharmacological Study +7

Thermal rearrangement of the immunosuppressant FK-506

H. O. OK, Byron H. Arison, R.G. Ball et al. · Tetrahedron Letters · 1990 · 14 citations

Immunosuppressive Therapy, Immunology, Immunodominance +4

1–4 of 4